Adenosine Receptor Agonists Exhibit Anti-Platelet Effects and the Potential to Overcome Resistance to P2Y<sub>12</sub> Receptor Antagonists.

Molecules · 2019 · PMC6982709 · PMID 31905703

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In addition, NECA, regadenoson and LUF5835 were able to increase the inhibition of platelet function caused by the anti-thrombotic activity of P2Y 12 inhibitors (reduction of thrombus volume was up to 75% compared to P2Y 12 antagonist alone), although the changes did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.